Results 181 to 190 of about 14,468 (240)

Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review. [PDF]

Psychol Med
Caporuscio C, Poppe C, Gieselmann A, Repantis D.   +3 more
europepmc   +1 more source

The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. [PDF]

Brain Sci
Correa da Costa S, Bormann NL, Oesterle T, McGinnis MT, Ho MF, Vettleson-Trutza SA, Rummans T, Gold MS.   +7 more
europepmc   +1 more source

Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models. [PDF]

Can J Psychiatry
Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN.   +4 more
europepmc   +1 more source

Exploring practitioners' perceptions of health behavior changes associated with psychedelic experiences. [PDF]

Sci Rep
Carvalho LC, Encantado J, van Elk M, Moller AC, Cornelius T, Timmermann C, Veiga D, Teixeira PJ.   +7 more
europepmc   +1 more source

Inhaled N, N-dimethyltryptamine diminishes connectivity between the ventral tegmental area and the nucleus accumbens: relevance to pathologies of mesolimbic and mesocortical pathways. [PDF]

Sci Rep
Lima G, Soares C, Teixeira M, Pais M, Cabral C, Rijo P, Castelo-Branco M.   +6 more
europepmc   +1 more source

Psilocybin-induced modulation of visual salience processing. [PDF]

Neurosci Conscious
Muller S, Cavanna F, de la Fuente LA, Bruno N, D'Amelio TA, Pallavicini C, Tagliazucchi E.   +6 more
europepmc   +1 more source

Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes. [PDF]

Front Psychiatry
Kishon R, Cycowicz YM.
europepmc   +1 more source